Recent Findings Preliminary data suggest that GLP-1 RA can modulate crucial pathways in the pathogenesis of IBD, such as chronic inflammation circuits, intestinal tight junctions, and gut microbiome dysbiosis, setting the stage for human trials to investigate the role of these agents in the treatment of IBD among people with or without diabetes and obesity
( : ) 3
Makeup businesses can listen to what customers say about the real effects of adding glutathione to beauty products that are eaten or put on the skin
5): The market value of Novo Nordisk and Eli Lilly has surged by $700 billion, representing a nearly 10-fold increase over the cumulative revenue generated by GLP-1 products themselves
Initially developed to treat diabetes , it has gained recognition for its effectiveness in supporting weight loss
Heerspink HJL, Stefnsson BV, Correa-Rotter R et al (2020) Dapagliflozin in patients with chronic kidney disease